Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) ...Middle East

PR Newswire - News
Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
SAN DIEGO, Sept. 2, 2022 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced that the company granted equity awards to 25 new employees with a grant date of September 1, 2022, as equity inducement awards outside of the...

Hence then, the article about mirati therapeutics reports inducement grant under nasdaq listing rule 5635 c 4 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News